|
ITSN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.065600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.864000E-01 |
| Normal-vs-Stage2 |
5.794400E-01 |
| Normal-vs-Stage3 |
5.865700E-02 |
| Normal-vs-Stage4 |
3.852000E-01 |
| Stage1-vs-Stage2 |
3.468400E-01 |
| Stage1-vs-Stage3 |
3.598500E-02 |
| Stage1-vs-Stage4 |
3.187200E-01 |
| Stage2-vs-Stage3 |
1.915200E-01 |
| Stage2-vs-Stage4 |
5.064600E-01 |
| Stage3-vs-Stage4 |
7.358600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.327200E-01 |
| Normal-vs-AfricanAmerican |
7.545600E-01 |
| Normal-vs-Asian |
4.895400E-01 |
| Caucasian-vs-AfricanAmerican |
9.635800E-01 |
| Caucasian-vs-Asian |
5.306000E-01 |
| AfricanAmerican-vs-Asian |
5.293000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.904000E-01 |
| Normal-vs-Female |
2.460400E-02 |
| Male-vs-Female |
1.073600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.656800E-01 |
| Normal-vs-Extreme_Weight |
1.097630E-01 |
| Normal-vs-Obese |
1.132430E-01 |
| Normal-vs-Extreme_Obese |
7.640800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.393400E-01 |
| Normal_Weight-vs-Obese |
1.778620E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.539000E-01 |
| Extreme_Weight-vs-Obese |
5.935000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.327000E-01 |
| Obese-vs-Extreme_Obese |
6.225200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.340300E-02 |
| Normal-vs-Age(41-60Yrs) |
7.852100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.436600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.599760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.952220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.701800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.135900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.597300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.807700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.209800E-01 |
| Normal-VS-Type2 PRCC |
6.491000E-01 |
| Normal-VS-KIRP CIMP |
1.304360E-02 |
| Normal-VS-Unclassified PRCC |
8.236100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.562800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.234250E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.318100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.132150E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.735500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.205500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.745000E-01 |
| Normal-vs-N1 |
7.859600E-03 |
| Normal-vs-N2 |
5.969400E-01 |
| N0-vs-N1 |
9.256800E-03 |
| N0-vs-N2 |
7.672200E-01 |
| N1-vs-N2 |
3.124800E-01 |
|
|
